Nexentis Technologies Inc.

NXTS | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.59

-$0.04 (-6.50%)

At close: Oct 30, 2026, 4:00 PM ET

$0.61

+$0.02 (+3.37%)

Pre-market: Nov 2, 2026, 4:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-6.50%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

44.8

+2.0 pts

Fundamentals Average

Market Sentiment Neutral

Moat None

Sector Rank #208/390 (Top 53%)

Full Analysis

Key Statistics

Market Data

Market Cap $33.13K

1D Range

0.54 0.61

52W Range

0.52 13.00

Valuation (TTM)

PE -0.03

PB 0.02

EV/EBITDA 0.97

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target $0.00

Cash Flow

FCF Yield -14086.4%

SBC Adj. FCF Yield -14415.5%

SBC Impact -2.3%

Margins

Gross Margin 263.6%

Operating Margin 17754.5%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -110.4% | -49.1%

Dil EPS 3Y | 5Y 135.7% | 40.7%

FCF 3Y | 5Y -49.9% | 3.6%

Returns

ROA -85.7%

ROE -161.0%

ROIC -72.5%

Financial Health

Net Cash

$8.46M

Current Ratio 3.72

Interest Coverage -24.93

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable ...

Sector Basic Materials

Industry Agricultural Inputs

Employees 8

IPO Date Feb 26, 2026

Website www.nexentistech.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.